Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

20228 citationsJournal Articlegold Open Access

Authors

Even if a small proportion of patients received a 1L IO, the data showed an improved survival outcomes in the Post-1L IO group.

Good health and well-being

Published in: Cancers

Volume 14, Issue 18, pp. 4481-4481

Field-Weighted Citation Impact: 0.73